MedTrace Logo

Ultrasound Guided Median Nerve Hydrodissection Using Dextrose

NCT05725460 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2023-09-29

No results posted yet for this study

Summary

to compare the efficacy of dextrose 5% with steroid hydrodissection in patients with carpal tunnel syndrome

Conditions

  • Carpal Tunnel Syndrome

Interventions

PROCEDURE

dextrose 5% median nerve hydrodissection

planned to be a good alternative to steroid hydrodissection

Sponsors & Collaborators

  • Iraqi Board of medical specialties

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-02-01
Primary Completion
2023-08-23
Completion
2023-09-13

Countries

  • Iraq

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05725460 on ClinicalTrials.gov